Triple
T23186532
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Mectizan |
E579606
|
entity |
| Predicate | adverseEffectRelatedTo |
P39645
|
FINISHED |
| Object | Mazzotti reaction in onchocerciasis |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Mazzotti reaction in onchocerciasis | Statement: [Mectizan, adverseEffectRelatedTo, Mazzotti reaction in onchocerciasis]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: adverseEffectRelatedTo Context triple: [Mectizan, adverseEffectRelatedTo, Mazzotti reaction in onchocerciasis]
-
A.
hasCommonAdverseEffect
Indicates that two or more entities share at least one adverse effect that occurs in response to them.
-
B.
commonAdverseReactions
Indicates that the related entities are linked through adverse reactions or side effects that frequently occur in association with one another.
-
C.
possibleSideEffect
chosen
Indicates that one entity may occur as a side effect or unintended consequence of another entity or action.
-
D.
associatedWithDrug
Indicates that an entity has a relevant relationship or connection to a specific drug, such as use, exposure, or involvement in its context.
-
E.
hasSeriousSideEffect
Indicates that an entity (such as a treatment, drug, or intervention) causes or is associated with a significant or severe adverse effect on another entity (typically a patient or biological system).
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e245ff8000819090d12008805315b7 |
completed | April 17, 2026, 2:38 p.m. |
| NER | Named-entity recognition | batch_69f18fd3aaa08190b9cf7afe4ee5a38d |
completed | April 29, 2026, 4:57 a.m. |
| PD | Predicate disambiguation | batch_69ef8a041c0081909afb670d17a5aaba |
completed | April 27, 2026, 4:08 p.m. |
Created at: April 17, 2026, 4:05 p.m.